IonQ (IONQ) director Jim Frankola receives 4,526-share RSU award
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
FRANKOLA JIM reported acquisition or exercise transactions in this Form 4 filing.
IonQ, Inc. director Jim Frankola reported an equity compensation grant rather than an open-market trade. He received 4,526 shares of common stock in the form of restricted stock units, with no cash paid per share, bringing his direct holdings to 8,939 shares after the award.
The RSUs vest in full on the earlier of the day before IonQ’s following year Annual Meeting or June 17, 2027, as long as he continues to serve on the Board of Directors through that date.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
FRANKOLA JIM
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 4,526 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 8,939 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
RSU award size: 4,526 shares
Price per share: $0.00 per share
Post-transaction holdings: 8,939 shares
+2 more
5 metrics
RSU award size
4,526 shares
Restricted stock unit grant to director Jim Frankola
Price per share
$0.00 per share
Reported transaction price for RSU-acquired common stock
Post-transaction holdings
8,939 shares
Total IonQ common shares directly held after grant
Vesting date latest
June 17, 2027
RSUs vest no later than this date if service continues
Alternative vesting trigger
Day before following Annual Meeting
Earlier vesting condition tied to next Annual Meeting
Key Terms
restricted stock unit ("RSU"), Annual Meeting, Board of Directors
3 terms
restricted stock unit ("RSU") financial
"Represents a restricted stock unit ("RSU") award."
Annual Meeting financial
"the day before the date of the following year's Annual Meeting"
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
Board of Directors financial
"service as a member of the Board of Directors through such vesting date"
The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.
FAQ
What insider transaction did IonQ (IONQ) director Jim Frankola report?
IonQ director Jim Frankola reported an equity compensation grant. He received 4,526 shares of common stock as a restricted stock unit (RSU) award, with no cash price per share, increasing his direct holdings to 8,939 shares after the grant.
Is Jim Frankola’s IonQ (IONQ) Form 4 a stock purchase or a grant?
The Form 4 reflects a grant, not a market purchase. Frankola received 4,526 IonQ common shares through a restricted stock unit (RSU) award as director compensation, with a reported price per share of $0.00, rather than buying shares in the open market.
When do Jim Frankola’s IonQ (IONQ) RSUs from this filing vest?
The RSUs vest in full on the earlier of two dates. They vest either the day before IonQ’s following year Annual Meeting or on June 17, 2027, provided Jim Frankola continues serving on the Board of Directors through the applicable vesting date.
Does the IonQ (IONQ) Form 4 mention any derivative securities for Jim Frankola?
The filing data provided show no derivative positions for this transaction. The derivativeSummary is empty, indicating the reported activity relates only to non-derivative common stock received through the restricted stock unit (RSU) award described in the Form 4.